Tech Center 1700 • Art Units: 1651 1656 1732
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18105890 | METHOD FOR PROMOTING THE RAPID PRECIPITATION OF TRAVERTINE CRYSTALS BY ALGAE | Non-Final OA | Fudan University |
| 18562933 | MICROORGANISM PRODUCING PURINE NUCLEOTIDES AND METHOD FOR PRODUCING PURINE NUCLEOTIDES USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18719160 | PROBIOTIC COMPOSITIONS AND THEIR USE IN MODULATING ALLERGY-TYPE INFLAMMATORY ACTIVITY | Non-Final OA | SYNBALANCE SRL |
| 18714839 | USE OF BIFIDOBACTERIUM LACTIS BL-99 IN PREVENTION AND/OR AMELIORATION OF GASTRITIS | Non-Final OA | INNER MONGOLIA DAIRY TECH RES INSTITUTE CO LTD |
| 17778587 | NEW USE OF BIFIDOBACTERIUM LACTIS BL-99 IN SUPPRESSION OF INTESTINAL INFLAMMATION | Non-Final OA | Inner Mongolia Dairy Tech Res Institute Co Ltd |
| 18704742 | RECOMBINANT YEAST CELL | Non-Final OA | DANISCO US INC. |
| 18609015 | Multi-strain probiotic formulation for ameliorating or preventing symptoms of treatment resistant depression | Non-Final OA | Unique Biotech Limited |
| 18588000 | WEIGHT LOSS SYNBIOTIC AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | Renhe Global (Shanghai) Grand Health Research Institute Co., Ltd. |
| 18543604 | METHODS FOR INCREASING MENTAL WELL-BEING AND/OR HAPPINESS | Non-Final OA | Fonterra Co-Operative Group Limited |
| 18499450 | METHOD OF USING A COMBINATION OF POSTBIOTICS AND PROBIOTICS FOR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION-ASSOCIATED DISORDERS | Non-Final OA | CHAMBIO CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy